Fitch places CFR's IDRs on Rating Watch Positive on proposed acquisition by Abbott

20-05-2014 Business Wire HealthComments (0)

Abbott LaboratoriesPharmaceuticalUSA

Fitch Ratings has placed all of the credit ratings of CFR Pharmaceuticals S.A. and its subsidiary CFR International SpA on Rating Watch Positive. A complete list of rating actions follows at the end of this press release. Today's action follows the announcement that Abbott Investments Luxembourg S.A.R.L., a subsidiary of Abbott Laboratories (Abbott; 'A+') has entered into a definitive agreement to acquire 72.62% of CFR's issued and outstanding shares from its controlli

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top